Literature DB >> 22160922

Engineering the chaperone network of CHO cells for optimal recombinant protein production and authenticity.

Lyne Jossé1, C Mark Smales, Mick F Tuite.   

Abstract

All proteins fold into a defined three-dimensional shape that is compatible with the cellular role and/or biological activity of those proteins. Molecular chaperones are a family of proteins whose role is to assist the folding and targeting of proteins in both normal and stressed cells. The rational manipulation of chaperone levels in a cell line engineered to produce a defined recombinant protein (rP) can significantly improve both the achievable steady-state levels and authenticity of a wide range of recombinant proteins. Here, we describe the methodology associated with expressing a variety of molecular chaperones in Chinese hamster ovary (CHO) lines in order to improve their recombinant protein production capacity. These chaperones include both those that facilitate the folding of the polypeptide chain (i.e. Hsp70, Hsp40) and those that can re-fold proteins that have misfolded in the cell (i.e. ClpB/Hsp104). This latter property is particularly important given the propensity for highly expressed recombinant proteins to misfold in the "foreign" cellular environment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22160922     DOI: 10.1007/978-1-61779-433-9_32

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  2 in total

1.  CHO-S antibody titers >1 gram/liter using flow electroporation-mediated transient gene expression followed by rapid migration to high-yield stable cell lines.

Authors:  Krista Steger; James Brady; Weili Wang; Meg Duskin; Karen Donato; Madhusudan Peshwa
Journal:  J Biomol Screen       Date:  2014-12-17

2.  Multi-omic profiling -of EPO-producing Chinese hamster ovary cell panel reveals metabolic adaptation to heterologous protein production.

Authors:  Daniel Ley; Ali Kazemi Seresht; Mikael Engmark; Olivera Magdenoska; Kristian Fog Nielsen; Helene Faustrup Kildegaard; Mikael Rørdam Andersen
Journal:  Biotechnol Bioeng       Date:  2015-06-30       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.